Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Z 103

Known as: Z-103 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Z-103 is a chelate compound consisting of zinc ion and L-carnosine. In this study, we investigated the protective effect of Z-103… Expand
1992
1992
Z-103 at 1 to 25 mg/kg, p.o. prevented 100% ethanol-induced gastric mucosal lesions in a dose-dependent manner. Z-103 at 3 to 25… Expand
1992
1992
The gastric mucosal adhesiveness of Z-103 in rats with acetic acid ulcer was studied macroscopically, histologically, and… Expand
Highly Cited
1991
Highly Cited
1991
The protective effect of a novel synthetic zinc-carnosine chelate compound, zinc N-(3-aminopropionyl)-L-histidine (Z-103), on the… Expand
1991
1991
Zinc compounds have been shown to antagonize various types of gastric ulceration in rats. Zinc carnosine (Z-103), a newly… Expand
Highly Cited
1991
Highly Cited
1991
A zinc-carnosine chelate compound, Z-103, attenuates gastric mucosal injuries and inhibits the increase of lipid peroxide in the… Expand
1990
1990
In the healing test of acetic acid ulcers in rats with limited food-intake-time, Z-103 given, p.o., at doses of 3 and 10 mg/kg… Expand
1990
1990
We investigated the anti-ulcer effects of zinc L-carnosine (Z-103) using several acute experimental models of gastric and… Expand
1990
1990
The objective of the present study was to examine the anti-free radical action of Z-103 in vitro. Z-103 is a novel synthetic… Expand
1989
1989
Z-103 (a novel anti-ulcer agent), given p.o. at doses of 30 and 100 mg/kg, significantly prevented gastric lesions induced by… Expand